tricyclic antidepressants

GPTKB entity

Statements (49)
Predicate Object
gptkbp:instanceOf class of medications
gptkbp:abbreviation gptkb:TCA
gptkbp:administeredBy oral route
gptkbp:contraindication severe liver disease
recent myocardial infarction
gptkbp:discoveredIn 1950s
gptkbp:drugClass analgesic
benzodiazepine
antidepressant
gptkbp:eliminationHalfLife varies by drug
gptkbp:example gptkb:doxepin
gptkb:desipramine
gptkb:amitriptyline
gptkb:imipramine
gptkb:clomipramine
gptkb:nortriptyline
gptkb:trimipramine
https://www.w3.org/2000/01/rdf-schema#label tricyclic antidepressants
gptkbp:interactsWith gptkb:beer
gptkb:monoamine_oxidase_inhibitors
anticholinergic drugs
antihypertensive drugs
gptkbp:legalStatus prescription only
gptkbp:marketedAs 1957
gptkbp:mechanismOfAction inhibit reuptake of norepinephrine and serotonin
gptkbp:metabolism liver
gptkbp:notableFor narrow therapeutic index
broad side effect profile
use in enuresis
use in neuropathic pain
gptkbp:pregnancyCategory varies by drug
gptkbp:replacedBy gptkb:selective_serotonin_reuptake_inhibitors
gptkbp:riskFactor QT prolongation
overdose toxicity
gptkbp:sideEffect gptkb:arrhythmia
gptkb:orthostatic_hypotension
constipation
blurred vision
weight gain
sedation
dry mouth
urinary retention
gptkbp:structure three-ring central structure
gptkbp:usedFor gptkb:depression
chronic pain
anxiety disorders
migraine prevention
gptkbp:bfsParent gptkb:CYP2D6
gptkbp:bfsLayer 5